-
Clinical, Cosmetic and Investigational Dermatology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Safety and efficacy of doxycycline in the treatment of rosacea
Review
(4133) Views (1542) Full article downloads
Authors: Sheila Valentín, Adisbeth Morales, Jorge L Sánchez, et al
Published Date August 2009
Volume 2009:2 Pages 129 - 140
DOI: http://dx.doi.org/10.2147/CCID.S4296
Sheila Valentín, Adisbeth Morales, Jorge L Sánchez, Abimael Rivera
Department of Dermatology, University of Puerto Rico, School of Medicine, San Juan, Puerto Rico
Abstract: Rosacea is a common, chronic, skin condition characterized by recurrent episodes of facial flushing, transient or persistent erythema, papules, pustules, and telangiectasias, in a symmetrical facial distribution. The etiology of rosacea remains unknown and this condition represents a therapeutic challenge because of its chronic nature, progression, potential for disfigurement and psychological impact. Although there is no curative therapy for rosacea, the most widely used systemic agents are oral tetracycline derivatives, including tetracycline, doxycycline, and minocycline. This article reviews the available evidence for the use of doxycycline, a second-generation tetracycline, in the treatment or rosacea.
Keywords: rosacea, doxycyline, tetracyclines
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
- Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology
- Update on the management of chronic eczema: new approaches and emerging treatment options
- Management of superficial basal cell carcinoma: focus on imiquimod
- An update on the management of acne vulgaris




